Allergan CEO Saunders' 'Un-American' Claim Earns White House Rebuke
This article was originally published in The Tan Sheet
Allergan CEO Brent Saunders calls Treasury’s proposals to block tax-inversion deals un-American, but the White House says consumers are on its side. Saunders makes his charges after Allergan and Pfizer terminate a planned merger to create a firm based in Ireland with a significantly lower tax rate.
Register for our free email digests: